[1]冷 俊,郁 淼,秦 兵,等.血清可溶性生长刺激表达基因2蛋白、胱抑素C、C反应蛋白与冠状动脉病变严重程度的相关性及预后影响因素分析[J].陕西医学杂志,2025,54(1):114-117,122.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.023]
　LENG Jun,YU Miao,QIN Bing,et al.Correlation between serum sST2,CysC,CRP and severity of coronary artery disease and prognostic factors[J].,2025,54(1):114-117,122.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.023]
点击复制

血清可溶性生长刺激表达基因2蛋白、胱抑素C、C反应蛋白与冠状动脉病变严重程度的相关性及预后影响因素分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年1期
页码:
114-117,122
栏目:
临床检验
出版日期:
2025-01-05

文章信息/Info

Title:
Correlation between serum sST2,CysC,CRP and severity of coronary artery disease and prognostic factors
作者:
冷 俊; 郁 淼; 秦 兵; 张 莉
(上海健康医学院附属崇明医院检验科,上海 202150)
Author(s):
LENG Jun; YU Miao; QIN Bing; ZHANG Li
(Department of Clinical Laboratory,Chongming Hospital,Affiliated to Shanghai University of Medicine and Health Sciences,Shanghai 202150,China)
关键词:
可溶性生长刺激表达基因2蛋白;  胱抑素C;  C反应蛋白;  冠状动脉病变;  相关性;  预后;  影响因素
Keywords:
Soluble growth STimulation expressed gene2;  Cystatin C;  C-reactive protein;  Coronary artery disease;  Relevance;  Prognosis;  Influence factor
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2025.01.023
文献标志码:
A
摘要:
目的:探究血清可溶性生长刺激表达基因2蛋白(sST2)、胱抑素C(Cys C)、C反应蛋白(CRP)与冠状动脉病变严重程度的相关性并分析预后的影响因素。方法:选取170例冠状动脉病变患者为观察组,以冠状动脉病变严重程度分为轻度狭窄组(53例)、中度狭窄组(62例)、重度狭窄组(55例),并选同期100例健康体检者为对照组。比较不同组别患者血清sST2、CysC、CRP水平差异,Pearson相关性分析其与冠状动脉病变严重程度的关系。对所有患者进行6个月随访,预后良好(118例)、预后不良(52例),以多元Logistic回归分析影响预后的危险因素。结果:观察组血清sST2、CysC、CRP水平较对照组升高(均P<0.05)。重度狭窄组患者血清sST2、CysC、CRP水平高于轻度、中度狭窄组,中度狭窄组高于轻度狭窄组(均P<0.05)。Pearson相关性分析显示,冠状动脉病变严重程度与血清sST2(r=0.727)、CysC(r=0.644)、CRP(r=0.889)均表现为显著正相关(均P<0.05)。多元Logistic回归分析显示,高血压史、糖尿病史、高血脂症、病变血管、经皮冠状动脉介入术使用支架类型、sST2与CysC均为影响预后的独立危险因素(均P<0.05)。结论:冠状动脉病变程度越严重,患者血清sST2、CysC、CRP水平越高,且高血压史、糖尿病史、高血脂症、病变血管、经皮冠状动脉介入术使用支架类型、sST2与CysC均是影响患者预后的独立危险因素。
Abstract:
Objective:To investigate the correlation between serum soluble growth STimulation expressed gene2(sST2),Cystatin C(Cys C)and C-reactive protein(CRP)and the severity of coronary artery disease,and to analyze the influencing factors of prognosis.Methods:A total of 170 patients with coronary artery disease were selected as the observation group,and divided into mild stenosis group(53 cases),moderate stenosis group(62 cases)and severe stenosis group(55 cases)according to the severity of coronary artery disease,and 100 healthy subjects were selected as the control group.The serum sST2,CysC and CRP levels in different groups were compared,and Pearson correlation analysis was conducted to analyze the relationship between sST2,CYSC and CRP levels and the severity of coronary artery disease.All patients were followed up for 6 months,and the prognosis was good(118 cases)and poor(52 cases).Multiple Logistic regression was used to analyze the risk factors affecting the prognosis.Results:The levels of sST2,CysC and CRP in the observation group were higher than those in the control group(all P<0.05).The levels of sST2,CysC and CRP in patients with severe stenosis were higher than those in mild and moderate stenosis groups,and those in moderate stenosis group were higher than those in mild stenosis group(all P<0.05).Pearson correlation analysis showed that the severity of coronary artery disease was significantly positively correlated with serum sST2(r=0.727),CysC(r=0.644)and CRP(r=0.889)(all P<0.05).Multiple Logistic regression analysis showed that history of hypertension,history of diabetes,hyperlipidemia,diseased vessels,stent type used in percutaneous coronary intervention,sST2 and CysC were independent risk factors for prognosis(all P<0.05).Conclusion:The more severe the degree of coronary artery disease,the higher the levels of serum sST2,CysC and CRP.Besides,history of hypertension,history of diabetes,hyperlipidemia,diseased vessels,type of stent used in percutaneous coronary intervention,sST2 and CysC are all independent risk factors affecting the prognosis of patients,which should be paid clinical attention.

参考文献/References:

[1] KATTA N,LOETHEN T,LAVIE C J,et al.Obesity and coronary heart disease:Epidemiology,pathology,and coronary artery sST2ging[J].Curr Probl Cardiol,2021,46(3):100655.
[2] 李睿,崔新景,陈吉彬,等.超声技术综合评价颈动脉粥样硬化与冠心病病变程度的相关性研究[J].中国循证心血管医学杂志,2021,13(2):166-169.
[3] DING H S,YANG J.Fluvastatin attenuated ischemia/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1/TLR4 signaling pathway[J].Mol Biol Rep,2021,48(5):3893-3901.
[4] 朱晓平,罗文强,南方,等.胱抑素C、血脂及血糖联合检测对动脉粥样硬化患者的诊断价值[J].陕西医学杂志,2017,46(9):1293-1295,1317.
[5] 冷世帅.不稳定型心绞痛中医证型与冠脉病变程度及心率变异性关系的研究[D].沈阳:辽宁中医药大学,2017.
[6] 陈瑞锋,黄洁,徐占岭,等.植入BP-SES治疗冠心病的临床疗效及预后影响因素分析[J].中西医结合心脑血管病杂志,2020,18(20):3447-3450.
[7] 田晶,杨弘,陈鑫龙,等.冠心病合并心力衰竭患者死亡风险Cox回归模型分析[J].中国循证心血管医学杂志,2020,12(6):683-686.
[8] 王建,刘晓红,陈若诗,等.血清胱抑素C与常见心血管疾病的关系[J].中国介入心脏病学杂志,2020,28(10):585-588.
[9] 严晓鑫,陈阳,石新慧,等.增龄对血小板中炎症标志物CRP、TNF-α和IL-10表达的影响[J].军事医学,2020(5):385-389.
[10] 谷斌杰,郝鑫鑫,王超慧,等.首发急性脑梗死大动脉粥样硬化型患者伴胱抑素C水平异常的相关危险因素分析[J].脑与神经疾病杂志,2020,28(1):14-17.
[11] ETLI M.Investigation of serum ischemia-modified albumin levels in coronary artery disease patients[J].Indian J Thorac Cardiovasc Surg,2021,37(2):147-152.
[12] CHEN X,LIN Y,TIAN L,et al.Correlation between ischemia-modified albumin level and coronary collateral circulation[J].BMC Cardiovasc Disord,2020,20(1):326.
[13] 方秋珏,王昭军,袁伟,等.可溶性ST2与冠脉复杂病变及其严重程度的相关性[J].中国临床药理学与治疗学,2021,26(3):278-284.
[14] 张怡靓,常晓红,孙钧,等.冠心病患者血浆sST2水平、心电图QRS波时限与冠状动脉病变程度的关系[J].山东医药,2020,60(33):79-82.
[15] 邵博一,娄明,冯春光.可溶性ST2对冠状动脉介入治疗的AMI患者预后的影响[J].江苏医药,2020,46(8):799-802.
[16] 陈明,张月兰.血清可溶性生长刺激表达因子2水平与急性ST段抬高型心肌梗死患者冠状动脉病变程度及短期预后的相关性分析[J].中国医科大学学报,2023,52(7):595-600.
[17] GÖK M,KUNDI H,KIZILTUNC E,et al.The relationship between ischaemia-modified albumin and good coronary collateral circulation[J].Kardiol Pol,2018,76(2):370-375.
[18] 刘翠平,罗艳丽,刘素霞.LP(a)、Hcy、HS-CRP联合检测在老年下肢动脉粥样硬化中的临床意义[J].河北医药,2008,30(4):436-437.
[19] 李蓓,王蕾,韩笑,等.高敏C反应蛋白及正五聚体蛋白-3与急性心肌梗死后室性心律失常的关系研究[J].保健医学研究与实践,2023,20(2):24-28.
[20] 李法强,纪艾玲,王帅帅.急性缺血性脑血管病患者脑动脉粥样硬化性狭窄分布及危险因素[J].中国实用神经疾病杂志,2023,26(3):339-343.
[21] 苏国兰,李华兴,康渭岚,等.Lp-PLA2水平与急性动脉粥样硬化脑梗死患者常见危险因素的相关性分析[J].现代诊断与治疗,2023,34(9):1269-1271,1312.
[22] 吉锋,李展绒,任耀龙,等.化痰通瘀除痹方治疗冠心病合并颈动脉粥样硬化斑块痰瘀困阻证疗效研究[J].陕西中医,2022,43(9):1212-1214.
[23] MANRESA-ROCAMORA A,RIBEIRO F,CASANOVA-LIZON A,et al.Cardiac rehabilitation improves endothelial function in coronary artery disease patients[J].Int J Sports Med,2022,43(11):905-920.
[24] 王大鹏,冯玉婧,裴建军,等.药物涂层球囊扩张成形术对颈动脉支架内再狭窄患者术后再狭窄及炎症因子水平的影响[J].中国医刊,2023,58(4):409-412.
[25] 刘超,吕茜.对紫杉醇药物涂层球囊与乐普支架治疗冠状动脉粥样硬化性心脏病疗效及预后分析[J].贵州医药,2022,46(8):1267-1268.

相似文献/References:

[1]刘玉珊.老年动脉粥样硬化性心肌梗死患者血清胱抑素C水平与血管内皮细胞损伤相关性研究*[J].陕西医学杂志,2020,49(4):431.
　LIU Yushan..Relationship between serum cystatin C level and vascular endothelial cell injury in elderly patients with atherosclerotic myocardial infarction[J].,2020,49(1):431.
[2]郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义*[J].陕西医学杂志,2020,49(5):619.
　GUO Jianqiang,ZHAO Junhong,ZHANG Fendui,et al.Changes of serum HbA1c and CysC in patients with type 2 diabetic retinopathy and their clinical significance[J].,2020,49(1):619.
[3]张桐慧,王 玲,陈 玲.血清乙酰肝素酶、α-L-岩藻糖苷酶和胱抑素C预测2型糖尿病患者早期肾损害临床价值对比研究[J].陕西医学杂志,2020,49(6):687.[doi:DOI:10.3969/j.issn.10007377.2020.06.012]
　ZHANG Tonghui,WANG Ling,CHEN Ling..Clinical value of serum heparanse,α-L-fucosidase and cystatin C in predicting early renal damage in patients with type 2 diabetes mellitus[J].,2020,49(1):687.[doi:DOI:10.3969/j.issn.10007377.2020.06.012]
[4]李春梦,王海峰,卢 佩,等.糖尿病肾病患者D-二聚体、纤维蛋白原、胱抑素C检测及临床意义*[J].陕西医学杂志,2020,49(11):1503.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.035]
　LI Chunmeng,WANG Haifeng,LU Pei,et al.Detection and clinical significance of D-dimer,fibrinogen,cystatin C in patients with diabetic nephropathy[J].,2020,49(1):1503.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.035]
[5]刘海波,许建秦,李春梦,等.胱抑素C和甘油三酯检测对糖尿病肾病的早期诊断价值研究[J].陕西医学杂志,2021,50(1):96.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.026]
　LIU Haibo,XU Jianqin,LI Chunmeng,et al.Value of cystatin C and triglyceride in early diagnosis of diabetic nephropathy[J].,2021,50(1):96.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.026]
[6]孙春晖,乐 原.川崎病合并冠状动脉病变患儿前白蛋白、胱抑素C、血小板四项变化及临床意义[J].陕西医学杂志,2021,50(12):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
　SUN Chunhui,LE Yuan.Changes and clinical significance of prealbumin,cystatin C and four parameters of platelet in Kawasaki disease children with coronary arterial lesions[J].,2021,50(1):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
[7]平 虎,蒲 燕,汤 进,等.心肌型脂肪酸结合蛋白、红细胞分布宽度、半胱氨酸天冬氨酸蛋白酶-3、基质金属蛋白酶-9、胱抑素C、肿瘤坏死因子-α联合检测对急性一氧化碳中毒患者预后的预测价值[J].陕西医学杂志,2022,51(11):1432.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.027]
[8]陶周善,吴兴净,周茂生,等.血清胱抑素C水平与不同性别老年患者股骨粗隆间骨折相关性研究[J].陕西医学杂志,2023,52(9):1155.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.009]
　TAO Zhoushan,WU Xingjing,ZHOU Maosheng,et al.Correlation between serum cystatin C level and intertrochanteric fracture in elderly patients of different genders[J].,2023,52(1):1155.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.009]
[9]曹志伟,张润春,王玉珍,等.癫痫患儿血清胱抑素C、脂蛋白相关磷脂酶A2水平与拉考沙胺添加治疗反应性关系及其预测价值[J].陕西医学杂志,2024,(3):372.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.018]
[10]李梦梦,张淑英,赵艳杰.视黄醇结合蛋白、胱抑素C、胃泌素前体释放肽水平联合超微血流成像在慢性肾脏病诊断中的价值研究[J].陕西医学杂志,2024,(4):483.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.010]
　LI Mengmeng,ZHANG Shuying,ZHAO Yanjie.Diagnostic value of RBP,CysC and proGRP in combination with superb micro-vascular imaging in chronic kidney disease[J].,2024,(1):483.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.010]

备注/Memo

备注/Memo:
基金项目:科技部国家重点研发计划课题(2019YFF0216502)
更新日期/Last Update: 2025-01-06